Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

BioInvent's BI-1206 to enter collaborative phase I/II trial

Jan. 21, 2015

Safety and dosing data presented for a novel gastric cancer vaccine

Jan. 19, 2015

OncoMed enrolls first biomarker-selected patient in anti-Notch 1 expansion trial

Jan. 16, 2015

Promising results presented for chimeric antigen receptors in B-cell cancer treatment

Jan. 15, 2015

Precision Biologics discloses interim survival data for NPC-1C in metastatic colorectal cancer

Jan. 15, 2015

EMA grants positive opinion for orphan drug status for enadenotucirev

Jan. 14, 2015

Asana BioSciences researchers prepare immunofusion molecules for cancer

Jan. 14, 2015

Phase III NSCLC trial stopped early after Opdivo shows superior overall survival to docetaxel

Jan. 13, 2015

OncoMed doses first patient in phase I trial of OMP-305B83

Jan. 12, 2015

cCAM Biotherapeutics cleared to begin phase I trial of CM-24 for cancer

Jan. 8, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...